Nicholas Donoghoe sold $2.6M of AbbVie (ABBV)

Executed Aug 5 2025, disclosed Aug 7 2025, 2 days later.

Value, as filed

$2.6M

13,295 sh across 2 lots

Executed

Aug 5 2025

the trade date, as filed

Disclosed

Aug 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

ND Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER profile →

Nicholas Donoghoe (EVP, CHIEF BUS/STRAT OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AbbVie Inc. (ABBV). The largest single filing was $8.2M of ABBV (32,710 sh × $250.00, as filed), executed Aug 14.

The name

ABBV AbbVie Inc. ABBV · Healthcare · 41 filings in 24 months ticker →

Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Nicholas Donoghoe in ABBV

ABBVSALE AbbVie Inc. $8.2M
32,710 sh × $250.00
Exec Aug 14
Filed Aug 18 · 5:00 PM ET